SACHIKO NAKASHIMA: Open Payments
NPI 1699029561 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 23 payments from 8 companies in 2025. Trend: 2023 $332 · 2024 $307 · 2025 $452
Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $192 |
| Lilly USA, LLC | 5 | $88 |
| Exact Sciences Corporation | 3 | $61 |
| Hologic Sales and Service, LLC | 1 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Astellas Pharma US Inc | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: VRAYLAR, QULIPTA, MOUNJARO, The Cologuard Plus Collection Kit, JARDIANCE, APTIMA, CAPLYTA, Veozah.
Industry payments across TX — which companies pay providers there.
